Sarah Josefsson

Bilde av Sarah Josefsson
English version of this page
Brukernavn
Besøksadresse Ullernchausseen 70 None 0372 OSLO
Postadresse Postboks 4950 Nydalen 0424 OSLO
Andre tilknytninger Det medisinske fakultet (Student)

Publikasjoner

  • Josefsson, Sarah Elisabet; Beiske, Klaus; Blaker, Yngvild Nuvin; Førsund, Mette S; Holte, Harald; Østenstad, Bjørn; Kimby, Eva; Köksal, Hakan; Wälchli, Sébastien; Bai, Baoyan; Smeland, Erlend B; Levy, Ronald; Kolstad, Arne; Huse, Kanutte & Myklebust, June (2019). TIGIT and PD-1 mark intratumoral T cells with reduced effector function in B-cell non-Hodgkin lymphoma. Cancer immunology research.  ISSN 2326-6066.  7(3), s 355- 362 . doi: 10.1158/2326-6066.CIR-18-0351 Fulltekst i vitenarkiv.
  • Köksal, Hakan; Dillard, Pierre; Josefsson, Sarah Elisabet; Maggadottir, Solrun Melkorka; Pollmann, Sylvie Mireille; Fåne, Anne; Blaker, Yngvild Nuvin; Beiske, Klaus; Huse, Kanutte; Kolstad, Arne; Holte, Harald; Kvalheim, Gunnar; Smeland, Erlend B; Myklebust, June Helen; Inderberg, Else Marit & Wälchli, Sébastien (2019). Preclinical development of CD37CAR T-cell therapy for treatment of B-cell lymphoma. Blood Advances.  ISSN 2473-9529.  3(8), s 1230- 1243 . doi: 10.1182/bloodadvances.2018029678 Fulltekst i vitenarkiv.
  • Josefsson, Sarah Elisabet Göthberg; Huse, Kanutte; Kolstad, Arne; Beiske, Klaus; Pende, Daniela; Steen, Chloe Beate; Inderberg, Else Marit; Lingjærde, Ole Christian; Østenstad, Bjørn; Smeland, Erlend B; Levy, Ronald; Irish, Jonathan M. & Myklebust, June (2017). T cells expressing checkpoint receptor TIGIT are enriched in follicular lymphoma tumors and characterized by reversible suppression of T-cell receptor signaling. Clinical Cancer Research.  ISSN 1078-0432.  24(4), s 870- 881 . doi: 10.1158/1078-0432.CCR-17-2337 Fulltekst i vitenarkiv.

Se alle arbeider i Cristin

Publisert 13. feb. 2019 12:34 - Sist endret 20. feb. 2019 11:07